Abstract
Aim: The majority of clear cell renal cell carcinoma patients develop resistance to mTOR inhibitors. Materials & methods: As an in vitro model four cell lines were used: HKC-8, 786- O, RCC-FG-2 and...
Funding Information
  • Norte Portugal Regional Operational Programme (SFRH/ BPD/111114/2015)
  • Research Center of the Portuguese Oncology Institute of Porto

This publication has 30 references indexed in Scilit: